NFKB1 and cancer: Nuclear factor-κB (NF-κB), which promotes inflammation, is a central mediator of the inflammatory process, and activation of NF-κB is also prevalent in cancer, which is mainly driven by inflammatory cytokines in the tumor microenvironment [41]; thus, inflammation promotion plays a crucial role in tumorigenesis.